The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience

被引：127

作者：

Doshi, Peter ^{[1
]}

Jefferson, Tom ^{[2
]}

Del Mar, Chris ^{[3
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA

[2] Cochrane Collaborat, Rome, Italy

[3] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Australia

来源：

PLOS MEDICINE | 2012年 / 9卷 / 04期

关键词：

UPPER GASTROINTESTINAL TOXICITY; NEURAMINIDASE INHIBITORS; ADVISORY-COMMITTEE; ROSIGLITAZONE; ROFECOXIB; INFLUENZA; COMPLICATIONS; OSELTAMIVIR; NAPROXEN; SAFETY;

D O I：

10.1371/journal.pmed.1001201

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6